These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 11350486)
1. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Hou YH; Srour EF; Ramsey H; Dahl R; Broxmeyer HE; Hromas R Blood; 2005 May; 105(9):3488-92. PubMed ID: 15650059 [TBL] [Abstract][Full Text] [Related]
2. Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment. Bonnevaux H; Guerif S; Albrecht J; Jouannot E; De Gallier T; Beil C; Lange C; Leuschner WD; Schneider M; Lemoine C; Caron A; Amara C; Barrière C; Siavellis J; Bardet V; Luna E; Agrawal P; Drake DR; Rao E; Wonerow P; Carrez C; Blanc V; Hsu K; Wiederschain D; Fraenkel PG; Virone-Oddos A Oncoimmunology; 2021; 10(1):1945803. PubMed ID: 34484869 [TBL] [Abstract][Full Text] [Related]
3. Overcoming adaptive therapy resistance in AML by targeting immune response pathways. Melgar K; Walker MM; Jones LM; Bolanos LC; Hueneman K; Wunderlich M; Jiang JK; Wilson KM; Zhang X; Sutter P; Wang A; Xu X; Choi K; Tawa G; Lorimer D; Abendroth J; O'Brien E; Hoyt SB; Berman E; Famulare CA; Mulloy JC; Levine RL; Perentesis JP; Thomas CJ; Starczynowski DT Sci Transl Med; 2019 Sep; 11(508):. PubMed ID: 31484791 [TBL] [Abstract][Full Text] [Related]
4. CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value. Pardanani A; Reichard KK; Zblewski D; Abdelrahman RA; Wassie EA; Morice Ii WG; Brooks C; Grogg KL; Hanson CA; Tefferi A; Chen D Leukemia; 2016 Apr; 30(4):914-8. PubMed ID: 26678095 [TBL] [Abstract][Full Text] [Related]
5. miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells. Zhang H; Goudeva L; Immenschuh S; Schambach A; Skokowa J; Eiz-Vesper B; Blasczyk R; Figueiredo C Mol Med; 2015 Apr; 20(1):736-46. PubMed ID: 25730818 [TBL] [Abstract][Full Text] [Related]
6. Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Busfield SJ; Biondo M; Wong M; Ramshaw HS; Lee EM; Ghosh S; Braley H; Panousis C; Roberts AW; He SZ; Thomas D; Fabri L; Vairo G; Lock RB; Lopez AF; Nash AD Leukemia; 2014 Nov; 28(11):2213-21. PubMed ID: 24705479 [TBL] [Abstract][Full Text] [Related]
7. High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model. van de Ven R; Verbrugge SE; Reurs AW; Bontkes HJ; Hooijberg E; Jansen G; Scheper RJ; Scheffer GL; de Gruijl TD Cancer Immunol Immunother; 2011 Jul; 60(7):943-51. PubMed ID: 21431918 [TBL] [Abstract][Full Text] [Related]
8. Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. Van Belle W; Anensen N; Haaland I; Bruserud Ø; Høgda KA; Gjertsen BT BMC Bioinformatics; 2006 Apr; 7():198. PubMed ID: 16606449 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression. Bradbury DA; Zhu YM; Russell NH Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652 [TBL] [Abstract][Full Text] [Related]
10. Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. De Waele M; Renmans W; Vander Gucht K; Jochmans K; Schots R; Otten J; Trullemans F; Lacor P; Van Riet I Eur J Haematol; 2001 Mar; 66(3):178-87. PubMed ID: 11350486 [TBL] [Abstract][Full Text] [Related]
12. Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood. De Waele M; Renmans W; Asosingh K; Vander Gucht K; Van Riet I Eur J Haematol; 2004 Mar; 72(3):193-202. PubMed ID: 14962238 [TBL] [Abstract][Full Text] [Related]
13. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
14. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts. De Waele M; Renmans W; Jochmans K; Schots R; Lacor P; Trullemans F; Otten J; Balduck N; Vander Gucht K; Van Camp B; Van Riet I Eur J Haematol; 1999 Sep; 63(3):192-201. PubMed ID: 10485274 [TBL] [Abstract][Full Text] [Related]